Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.53
Delayed Data
As of Jul 31
 +0.15 / +2.35%
Today’s Change
4.40
Today|||52-Week Range
15.24
-34.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues36.1K1.3M2.4M4.1M
 
 
 
 
 
Cost of Goods Sold11.8K264.7K1.8M2.1M
 
 
 
 
 
Depreciation And Amortization39.2K54.6K64.4K65.5K
 
 
 
 
 
 
Operating ExpensesGross Income-14.8K1.0M511.1K2.0M
 
 
 
 
 
General Expenses4.4M3.9M5.2M9.3M
 
 
 
 
 
Other Operating Expenses0.00627.2K0.000.00
 
 
Research And Development2.9M2.5M1.7M2.4M
 
 
 
 
 
Total Operating Expenses4.5M4.8M7.1M11.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.4M-3.5M-4.7M-7.3M
 
 
 
 
 
Extraordinary Charge0.000.000.00-2.1M
 
 
Interest Expense On Debt1.0M564.4K422.8K310.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.5M-4.1M-5.1M-9.7M
 
 
 
 
 
Income Taxes0.00-391.8K-458.3K-385.6K
 
 
 
 
Preferred Dividend-3.1M-2.5M-2.4M-9.3M
 
 
 
 
 
Net Income-5.5M-3.7M-4.7M-9.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.4M7.9M9.4M14.4M
 
 
 
 
 
Shares To Calculate EPS Diluted6.4M7.9M9.4M14.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.25-$0.75-$0.75-$1.29
 
 
 
 
 
EPS Diluted-$1.25-$0.75-$0.75-$1.29